Barinthus Biotherapeutics (BRNS) Research & Development (2020 - 2026)
Barinthus Biotherapeutics' Research & Development was $3.92 million in Q2 2026, down 50.7% from $7.95 million a year earlier but up 9.2% from the prior quarter.
Powered by 
Analysis
Barinthus Biotherapeutics (BRNS) Research & Development (2020 - 2026) Analysis & Trends
On a trailing twelve-month basis, Barinthus Biotherapeutics' Research & Development was $16.84 million through Jun 30, 2026, down 52.8% year-over-year; for FY2025, it was $25.56 million, down 39.5% from FY2024.
- Research & Development shows a five-year compound annual growth rate of 12.2% (FY2020 to FY2025).
- In earlier years, Research & Development was $42.24 million in FY2024 (-5.9%), $44.87 million in FY2023 (+6.0%), $42.35 million in FY2022 (+107.9%) and $20.37 million in FY2021 (+41.6%).
- Quarterly Research & Development has moved between $3.59 million (Q1 2026) and $15.14 million (Q3 2023) over five years.
- Compared with a year earlier, Research & Development has declined for six straight quarters, with an average decline of 33.1% over the last eight quarters.
- The best year-over-year quarter for Research & Development over five years was Q4 2021 (growth of 168.2%); the worst was Q1 2026 (a decline of 56.7%).
- Per Business Quant data, BRNS's Research & Development in the three quarters before Q2 2026 was $3.59 million (Q1 2026), $3.93 million (Q4 2025) and $5.39 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 3.65 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 2.34 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 9.74 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | -2.85 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -4.05 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 1.87 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 1.76 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 2.81 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 993.80 Mn |
| 10 | Barinthus Biotherapeutics | 30.23 Mn | 30.29 Mn | - | 3.92 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3.92 Mn |
| Mar 31, 2026 | 3.59 Mn |
| Dec 31, 2025 | 3.93 Mn |
| Sep 30, 2025 | 5.39 Mn |
| Jun 30, 2025 | 7.95 Mn |
| Mar 31, 2025 | 8.29 Mn |
| Dec 31, 2024 | 8.31 Mn |
| Sep 30, 2024 | 11.14 Mn |
| Jun 30, 2024 | 11.66 Mn |
| Mar 31, 2024 | 11.13 Mn |
| Dec 31, 2023 | 6.37 Mn |
| Sep 30, 2023 | 15.14 Mn |
| Jun 30, 2023 | 13.54 Mn |
| Mar 31, 2023 | 9.81 Mn |
| Dec 31, 2022 | 12.19 Mn |
| Sep 30, 2022 | 9.74 Mn |
| Jun 30, 2022 | 9.72 Mn |
| Mar 31, 2022 | 10.70 Mn |
| Dec 31, 2021 | 6.88 Mn |
| Sep 30, 2021 | 4.37 Mn |
API Access
Barinthus Biotherapeutics Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=BRNS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "BRNS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=BRNS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();